Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
- Author(s)
- Wines, BD; Kurtovic, L; Trist, HM; Esparon, S; Lopez, E; Chappin, K; Chan, LJ; Mordant, FL; Lee, WS; Gherardin, NA; Patel, SK; Hartley, GE; Pymm, P; Cooney, JP; Beeson, JG; Godfrey, DI; Burrell, LM; van Zelm, MC; Wheatley, AK; Chung, AW; Tham, WH; Subbarao, K; Kent, SJ; Hogarth, PM;
- Journal Title
- Frontiers in Immunology
- Abstract
- [This corrects the article doi: 10.3389/fimmu.2022.889372].
- Publisher
- Frontiers Media
- Keywords
- ACE2-Fc; Adcc; Covid-19; SARS-CoV-2; antibody effector function; complement; coronavirus; neutralization
- Research Division(s)
- Infectious Diseases And Immune Defence
- PubMed ID
- 36703991
- Publisher's Version
- https://doi.org/10.3389/fimmu.2022.1122516
- Open Access at Publisher's Site
https://doi.org/10.3389/fimmu.2022.1122516- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-04-13 11:09:58
Last Modified: 2023-04-13 12:10:18